Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Hagenbeek, Anton, Mooij, Hans, Zijlstra, Josée, Lugtenburg, Pieternella, van Imhoff, Gustaaf, Nijland, Marcel, Tonino, Sanne, Hutchings, Martin, Spiering, Marjolein, Liu, Roberto, van Tinteren, Harm, Kersten, Marie José
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2019
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442967/
https://ncbi.nlm.nih.gov/pubmed/30381303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.196899
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados